Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting (Q39158144)

9 September 2017

Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting (English)

1 reference

9 September 2017

0 references

6

1 reference

9 September 2017

7

Duane Gubler

1 reference

William John Hannan McBride

9 September 2017

John McBride

15

0 references

Joseph Torresi

Joseph Torresi

24

0 references

Eng Eong Ooi

Eng Eong Ooi

19

0 references

Yee-Sin Leo

12

Yee Sin Leo

1 reference

Pedro Fernando da Costa Vasconcelos

9 September 2017

25

Pedro Vasconcelos

1 reference

9 September 2017

26

Dewa Nyoman Wirawan

1 reference

9 September 2017

27

Sutee Yoksan

1 reference

9 September 2017

Sai Kit Lam

1

1 reference

9 September 2017

Donald Burke

2

1 reference

9 September 2017

Maria Rosario Capeding

3

1 reference

9 September 2017

Chee Keong Chong

4

1 reference

9 September 2017

Laurent Coudeville

5

1 reference

9 September 2017

Sri Rezeki Hadinegoro

8

1 reference

9 September 2017

Jeffrey Hanna

9

1 reference

9 September 2017

Jean Lang

10

1 reference

9 September 2017

Han Lim Lee

11

1 reference

9 September 2017

Chan Quang Luong

13

1 reference

9 September 2017

Richard Mahoney

14

1 reference

9 September 2017

Jorge Mendez-Galvan

16

1 reference

9 September 2017

Lee Ching Ng

17

1 reference

9 September 2017

Suchitra Nimmannitya

18

1 reference

9 September 2017

Donald Shepard

20

1 reference

9 September 2017

Jaco Smit

21

1 reference

9 September 2017

Rémy Teyssou

22

1 reference

9 September 2017

Laurent Thomas

23

1 reference

9 September 2017

language of work or name

English

0 references

publication date

22 August 2011

1 reference

9 September 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

9 September 2017

29

1 reference

9 September 2017

9417-9422

1 reference

9 September 2017

51

1 reference

Dengue: a continuing global threat

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Effect of dengue vector control interventions on entomological parameters in developing countries: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

National dengue surveillance in Cambodia 1980-2008: epidemiological and virological trends and the impact of vector control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Dengue prevention and 35 years of vector control in Singapore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Progress towards a dengue vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Immune response to dengue virus and prospects for a vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Dengue vaccine prospects: a step forward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

A policy framework for accelerating adoption of new vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

The introduction of new vaccines into developing countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Dengue v2V--new global initiative supporting transition from vaccine to vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

The WHO dengue classification and case definitions: time for a reassessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Economic impact of dengue illness in the Americas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Cost of dengue cases in eight countries in the Americas and Asia: a prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Health economics of dengue: a systematic literature review and expert panel's assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

High dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Cost-effectiveness of a pediatric dengue vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Cost and disease burden of dengue in Cambodia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Poverty, user fees and ability to pay for health care for children with suspected dengue in rural Cambodia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Out-of-pocket health expenditure and debt in poor households: evidence from Cambodia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Quality of life of dengue patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Travelling waves in the occurrence of dengue haemorrhagic fever in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

The impact of the demographic transition on dengue in Thailand: insights from a statistical analysis and mathematical modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Rotavirus vaccine introduction in the Americas: progress and lessons learned

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Forecasting dengue vaccine demand in disease endemic and non-endemic countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Antibody-enhanced dengue virus infection in primate leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Immunopathological mechanisms in dengue and dengue hemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Vaccine-induced enhancement of viral infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Adverse event reports following yellow fever vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Introducing HPV vaccine in developing countries--key challenges and issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Human papillomavirus vaccine introduction in Vietnam: formative research findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

Cost of plasma-derived hepatitis B vaccine production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.047

10.1016/J.VACCINE.2011.08.047

7 January 2021

Identifiers

DOI

1 reference

9 September 2017

1 reference